Outset Medical, Inc. (OM)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$242.4M
Stockholders' Equity
$96.3M
Cash & Equivalents
$35.0M
Long-Term Debt
$97.6M

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, Outset Medical, Inc. reported revenue of $31.6M, net income of -$18.0M, and total assets of $242.4M. Every figure below is taken directly from Outset Medical, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2018–FY2025 · as reported

$130.4M-$21.2M-$172.8M
FY2018FY2020FY2022FY2024FY2025
Revenue$119.5MNet income-$81.7M
FY2018 revenue
$2.0M
FY2025 revenue
$119.5M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$119.5M-$81.7M
FY2024$113.7M-$128.0M
FY2023$130.4M-$172.8M
FY2022$115.4M-$163.0M
FY2021$102.6M-$131.9M
FY2020$49.9M-$121.5M
FY2019$15.1M-$68.3M
FY2018$2.0M-$49.8M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KAug 28, 2026on EDGAR ↗
10-QAug 6, 2026on EDGAR ↗
8-KAug 6, 2026on EDGAR ↗
8-KJun 17, 2026on EDGAR ↗
8-KJun 5, 2026on EDGAR ↗
8-KMay 29, 2026on EDGAR ↗
8-KMay 7, 2026on EDGAR ↗
10-QMay 7, 2026on EDGAR ↗
DEF 14AApr 24, 2026on EDGAR ↗
10-KFeb 13, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$242.4Msource ↗
Stockholders’ Equity$96.3Msource ↗
Cash & Equivalents$35.0Msource ↗
Long-Term Debt$97.6Msource ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$31.6Msource ↗
Net Income-$18.0Msource ↗
Operating Income-$15.7Msource ↗
Gross Profit$13.3Msource ↗
Cost of Revenue$18.4Msource ↗
R&D Expense$5.5Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.97source ↗
EPS (basic)$-0.97source ↗
Shares Outstanding18.8Msource ↗
Cash from Operations-$9.6Msource ↗
Cash from Financing-$88,000source ↗
Cash from Investing$14.2Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
2
Sells
7
Net shares
+209.0K

Restatement history

Point-in-time

No material restatements detected across 220 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches OM’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/OM

MCP tool: get_sec_fundamentals ticker=OM

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/OM/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=OM as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/OM/history

MCP tool: get_fundamentals_history ticker=OM

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/OM

MCP tool: get_financial_health ticker=OM

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.